A Phase 2 Study of Enzalutamide in Patients With High-risk Prostate Cancer Who Have Undergone Local Definitive Therapy With Radical Prostatectomy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 13 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2019.
- 13 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 26 May 2017.